Comment on: “GLM7 – A Novel Composite Glycolipid Index Derived from Routine Health Indicators for Enhanced Diagnosis and Prediction of Multimorbidity”

The recent study by Wang et al. introduces GLM7, a novel composite index integrating routine health indicators to enhance the diagnosis and prediction of multimorbidity. The study provides compelling evidence for the utility of cost-effective biomarkers in large-scale health screening. In this comment, we engage in a constructive discussion regarding the methodological interpretation of the index. Specifically, we explore the implications of incorporating diagnostic criteria (such as fasting blood glucose) into predictive models for diabetes, the mathematical nuance required when comparing Odds Ratios (ORs) between logarithmic indices and linear variables, and the structural contribution of age within the composite formula. We believe that addressing these aspects could further solidify the clinical applicability and interpretability of GLM7.